Changsha Anxiang Medical Technology Co., Ltd. appears in FDA records as an applicant for Class II electrical stimulation devices under product codes NGX and NUH. The supplied collection holds one linked 510(k) record, K262470, decided Substantially Equivalent (SESE) on 2026-10-30, with a received date of 2026-07-17. That single linked record is the full collection count in this snapshot; it is not a measure of total company sales, total portfolio or safety performance. [1][2][3]
The K262470 dual-channel stimulator
K262470 covers the Dual-Channel TENS & EMS Muscle Stimulator, Models TS1111 and TS4111, filed by Changsha Anxiang Medical Technology Co., Ltd. The FDA record lists product code NGX, regulation 890.5850 for a powered muscle stimulator for muscle conditioning, Class II, Physical Medicine panel, Traditional clearance type, and a Statement rather than a summary. The decision description reads Substantially Equivalent. [1][3]
The same filing details appear in the FDA 510(k) premarket notification database entry, which shows the device name, applicant, date received 07/17/2026 and decision date 10/30/2026 under the Physical Medicine specialty. FDA.report's PMN page repeats the product code, decision, regulation and classification name, and notes the review was not third-party reviewed. [2][3]
Earlier TENS and EMS clearances
An FDA substantial equivalence letter dated July 30, 2025 addresses K251706 for a TENS and EMS Unit under 21 CFR 890.5850, Class II, product code NGX, to Changsha Anxiang Medical Technology Co., LTD. The letter's indications text describes use for pain in the shoulder, waist, back, neck, upper and lower extremities, abdomen and bottom caused by exercise or normal household activities, and for stimulating healthy muscles to improve muscle performance; the form marks Over-The-Counter Use. [4]
A March 12, 2025 letter addresses K243763 for a Wireless TENS & EMS Unit under the same regulation and product code, and a July 28, 2025 letter addresses K251187 for a 3 in 1 TENS UNIT (TC1241, TC2241, TS1241) under 21 CFR 882.5890, product code NUH, with the same over-the-counter marking. An August 28, 2025 letter addresses K251429 for an OTC 4-Channel Rechargeable TENS Unit under 21 CFR 882.5890. [7][8][9]
Applicant identity and registration record
The applicant name on the K262470 record is Changsha Anxiang Medical Technology Co., Ltd., with a Changsha, Hunan address at 9th Floor, R&D Center and Supporting Projects 101, #18 Shaoshan Middle Rd., Dongtang St., Yuhua District, postal code 410000, and contact Yoyo Yang. The same street address appears in the 2025 clearance letters, where William (Qunqi) Fu is identified as General Manager. These are filing addresses, not a verified headquarters. [1][4]
FDA.report's company page lists registration 3017887847 for Changsha Anxiang Medical Technology Co., LTD with an expiration year of 2027-01-01 and initial importer marked N, and shows device listings including AUVON - TU3416 dated 2023-10-21. That page is a third-party index of public FDA datasets; no parent company, brand ownership or website is verified in the public documents. [5]
What the record set does and does not show
The linked collection contains one 510(k) record, and the decision count for that collection is one SESE. The smaller record sample also contains one SESE entry, K262470, so the two denominators coincide here and neither should be read as a broader portfolio total. No recall records appear in the supplied sample. [1][3]
The 2025 letters show a pattern of NGX and NUH filings for TENS and EMS devices, but the public documents do not establish manufacturing sites, quality certifications, customers, commercial availability or clinical performance. FDA.report notes that its data can change and that critical regulatory decisions should be verified against the official FDA source. [3][5]
